Biolipox Interim Report, January - March 2006

• Revenues for the first quarter amounted to SEK 11.1 million (0). • Earnings after tax amounted to SEK -16.8 million (-24.4) for the first quarter. • Earnings per share for the first quarter was SEK -23.66 (-30.77). • Cash-flow for the first quarter was positive and amounted to SEK 16.9 million (113.2). • Drug development projects advance according to plan Forthcoming financial information • Interim report, January – June 2006 29 August 2006 • Interim report, January – September 2006 19 October 2006 Biolipox’s interim report for the first quarter 2006 is presented on the following pages.